Ultimate Medicine AG, a Swiss preclinical pharmaceutical company, is developing an innovative oral treatment for age-related cognitive disorders. Our approach targets an overlooked pathway complementing standard amyloid-β/tau therapies.

Products, services, technology

Ultimate Medicine AG develops innovative oral therapies for Alzheimer’s and age-related cognitive decline. Our small molecule targets a novel disease pathway, addressing multiple impairment mechanisms with integrated biomarkers for patient selection and monitoring.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2019
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in